Disease

Obesity (BMI>30)

2 developments in the corpus

Following this puts new work involving it at the top of your briefing, with a note saying why it is there. Links are taken from the source record, never inferred.

Latest

Everything in the corpus, newest first.

AUG 20, 2026 · PHASE 4 TRIAL

Resistance Training to Prevent Muscle Loss During Treatment With Tirzepatide

ClinicalTrials.gov

This is a Phase 4 interventional trial registration with no results posted; it describes a planned study of resistance training to mitigate muscle loss during tirzepatide treatment, addressing a plausible but unproven clinical question.

PreliminaryResistance Training Obesity (BMI>30)Technical University of Munich

Reported

Planned enrollment150

PhasePHASE 4

Primary outcome measureChange in contractile thigh muscle volume (…

AUG 19, 2026 · OBSERVATIONAL STUDY

FABP4 Response After Roux-en-Y Gastric Bypass

ClinicalTrials.gov

Retrospective observational cohort study with small sample size (n=28) and no published results reported in this registry record; recruitment completed but outcomes not yet disclosed.

PreliminaryObesity (BMI>30)Insulin Resistance Istanbul University

Reported

Sample size28

Primary outcome measureChange in serum FABP4 level from baseline t…

Assessment time pointsBaseline, 3 months, 6 months